NCT04626843View on ClinicalTrials.gov

Intermittent Fasting and CLL/SLL

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

October 30, 2022

Study Completion Date

December 31, 2022

Conditions
NeoplasmsLeukemia, Lymphocytic, ChronicLymphoma, Small LymphocyticIntermittent FastingDiet HabitInflammation
Interventions
OTHER

Intermittent fast

16/8 fasting method: fast for 16 hours of the day with an 8 hours feeding window for a duration of 3 months.

Trial Locations (1)

V8R 6V5

Eleah Stringer, Victoria

All Listed Sponsors
collaborator

BC Cancer Foundation

OTHER

lead

Eleah Stringer

OTHER

NCT04626843 - Intermittent Fasting and CLL/SLL | Biotech Hunter | Biotech Hunter